VORANIGO (vorasidenib) is used to treat certain forms of glioma.
It is an anti-cancer medication used for the treatment of certain forms of glioma. Vorasidenib is a dual mutant isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 (mIDH1/2) inhibitor.
| Brand Name: | VORANIGO |
| Generic Name: | vorasidenib |
| Strength: | Tablets: 10 mg and 40 mg. |
| Manufacturer: | Servier Pharmaceuticals |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
Get access to VORANIGO in India for certain forms of glioma treatment through Named-Patient Import in India.
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to VORANIGO (vorasidenib) tablets for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
